Human immunodeficiency virus · ORGANISM · Human immunodeficiency virus
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-13Confirm a stable target identifier before relying on this context across project surfaces.
Confirm a stable target identifier before relying on this context across project surfaces.
Human immunodeficiency virus
Review this target as Human immunodeficiency virus.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Human immunodeficiency virus as ChEMBL target CHEMBL613758. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Human immunodeficiency virus still has a stable protein naming contract across sources.
Jump to Protein ContextUse this block first when you need the strongest disease program and evidence level in one place.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Human immunodeficiency virus |
| Target Type | ORGANISM |
| Organism | Human immunodeficiency virus |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Human immunodeficiency virus |
| UniProt Accession | N/A |
Human immunodeficiency virus
Review this target as Human immunodeficiency virus.
| ChEMBL ID | pChEMBL | Type | Value (nM) | Phase |
|---|---|---|---|---|
| CHEMBL5314362 | 10.0 | EC50 | 0.1 | Approved |
| CHEMBL1078231 | 9.74 | IC50 | 0.18 | Preclinical |
| CHEMBL5397495 | 9.51 | IC50 | 0.31 | Preclinical |
| CHEMBL5395699 | 9.49 | IC50 | 0.32 | Preclinical |
| CHEMBL5412528 | 9.49 | IC50 | 0.32 | Preclinical |
| CHEMBL175691 | 9.46 | IC50 | 0.35 | Approved |
| CHEMBL269559 | 9.4 | EC50 | 0.4 | Preclinical |
| CHEMBL2403229 | 9.4 | IC50 | 0.4 | Preclinical |
| CHEMBL223228 | 9.3 | EC50 | 0.5 | Approved |
| CHEMBL223228 | 9.3 | IC50 | 0.5 | Approved |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| organism-based format | 525 | 1,167 | 7.0 |
| assay format | 1 | 1 | 8.0 |
| cell-based format | 1 | 0 | — |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| organism-based format | 5 | 0 | — |